Q2 2024 Holdings
Filed 2024-08-14 | 39 holdings | $863.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $143.3M | 2,138,963 | 16.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $93.0M | 1,130,167 | 10.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $89.6M | 9,029,843 | 10.4% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $85.0M | 266,914 | 9.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $67.0M | 289,050 | 7.8% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $65.8M | 1,381,619 | 7.6% |
| Alnylam Pharmaceuticals Inc | COM | 02043QAB3 | $44.5M | 183,123 | 5.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $39.3M | 2,418,841 | 4.6% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $34.4M | 1,666,378 | 4.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $31.9M | 201,683 | 3.7% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $20.1M | 803,641 | 2.3% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $17.0M | 2,116,403 | 2.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $13.5M | 5,257,086 | 1.6% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $11.9M | 495,592 | 1.4% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $11.0M | 1,010,833 | 1.3% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $10.6M | 2,350,190 | 1.2% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $9.6M | 561,908 | 1.1% |
| Align Technology Inc(ALGN) | COM | 016255101 | $9.1M | 37,772 | 1.1% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.3M | 405,193 | 1.0% |
| Acelyrin Inc | COM | 00445A100 | $7.6M | 1,715,180 | 0.9% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $6.3M | 750,371 | 0.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.1M | 111,717 | 0.7% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $5.7M | 6,277,093 | 0.7% |
| Elevation Oncology Inc | COM | 28623U101 | $4.9M | 1,800,106 | 0.6% |
| Bluebird BIO Inc | COM | 09609G100 | $4.6M | 4,633,351 | 0.5% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $4.4M | 5,102,193 | 0.5% |
| Verve Therapeutics Inc | COM | 92539P101 | $2.8M | 575,817 | 0.3% |
| Nuvation BIO Inc(NUVB) | COM | 67080N101 | $2.3M | 772,652 | 0.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.2M | 64,700 | 0.3% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $2.2M | 732,400 | 0.3% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $1.8M | 811,268 | 0.2% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $1.7M | 125,861 | 0.2% |
| Humana Inc(HUM) | COM | 444859102 | $1.5M | 3,985 | 0.2% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $910.1K | 110,719 | 0.1% |
| Vyne Therapeutics Inc Pipe(VYNE) | COM | 92941V308 | $877.5K | 445,434 | 0.1% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $746.3K | 225,465 | 0.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $626.8K | 569,832 | 0.1% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $424.3K | 150,475 | 0.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $411.1K | 24,500 | 0.0% |